Clinical trials
Phase 4 Diabetes Mellitus trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 4 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 4 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 4 |
| 2017 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Unknown status | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 8 |
| Eli Lilly and Company | 4 |
| Hospital Universitario La Paz | 3 |
| GlaxoSmithKline | 2 |
| Astellas Pharma Inc | 1 |
| Fundacion Investigacion Interhospitalaria Cardiovascular | 1 |
| Fundación Pública Andaluza Progreso y Salud | 1 |
| Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 1 |
| Hospital General Universitario Gregorio Marañon | 1 |
| Hospital Universitario Infanta Cristina | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus | 27 |
| Diabetes Mellitus, Type 2 | 17 |
| Sleep Apnea Syndromes | 3 |
| Insulin Resistance | 2 |
| Acute Coronary Syndrome | 1 |
| Albuminuria | 1 |
| Bronchitis, Chronic | 1 |
| Coronary Artery Disease | 1 |
| Diabetes Mellitus, Type 1 | 1 |
| Diabetic Nephropathies | 1 |
Trials
Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.